-
1
-
-
10744223326
-
Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability
-
A.D. Borthwick, D.E. Davies, P.F. Ertl, A.M. Exall, T.M. Haley, G.J. Hart, D.L. Jackson, N.R. Parry, A. Patikis, N. Trivedi, G.G. Weingarten, and J.M. Woolven Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability J. Med. Chem. 46 2003 4428 4449
-
(2003)
J. Med. Chem.
, vol.46
, pp. 4428-4449
-
-
Borthwick, A.D.1
Davies, D.E.2
Ertl, P.F.3
Exall, A.M.4
Haley, T.M.5
Hart, G.J.6
Jackson, D.L.7
Parry, N.R.8
Patikis, A.9
Trivedi, N.10
Weingarten, G.G.11
Woolven, J.M.12
-
2
-
-
0037042763
-
Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: Potency and plasma stability
-
A.D. Borthwick, A.M. Exall, T.M. Haley, D.L. Jackson, A.M. Mason, and G.G. Weingarten Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability Bioorg. Med. Chem. Lett. 12 2002 1719 1722
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 1719-1722
-
-
Borthwick, A.D.1
Exall, A.M.2
Haley, T.M.3
Jackson, D.L.4
Mason, A.M.5
Weingarten, G.G.6
-
3
-
-
12144287555
-
Structure-based optimization of novel azepane derivatives as PKB inhibitors
-
C.B. Breitenlechner, T. Wegge, L. Berillon, K. Graul, K. Marzenell, W.G. Friebe, U. Thomas, R. Schumacher, R. Huber, R.A. Engh, and B. Masjost Structure-based optimization of novel azepane derivatives as PKB inhibitors J. Med. Chem. 47 2004 1375 1390
-
(2004)
J. Med. Chem.
, vol.47
, pp. 1375-1390
-
-
Breitenlechner, C.B.1
Wegge, T.2
Berillon, L.3
Graul, K.4
Marzenell, K.5
Friebe, W.G.6
Thomas, U.7
Schumacher, R.8
Huber, R.9
Engh, R.A.10
Masjost, B.11
-
4
-
-
0345490845
-
Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450
-
W.F. Busby Jr., J.M. Ackermann, and C.L. Crespi Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450 Drug. Metab. Dispos. 27 1999 246 249
-
(1999)
Drug. Metab. Dispos.
, vol.27
, pp. 246-249
-
-
Busby Jr., W.F.1
Ackermann, J.M.2
Crespi, C.L.3
-
5
-
-
0031940804
-
Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes
-
N. Chauret, A. Gauthier, and D.A. Nicoll-Griffith Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes Drug. Metab. Dispos. 26 1998 1 4
-
(1998)
Drug. Metab. Dispos.
, vol.26
, pp. 1-4
-
-
Chauret, N.1
Gauthier, A.2
Nicoll-Griffith, D.A.3
-
6
-
-
0037523454
-
Profiling drug-like properties in discovery research
-
L. Di, and E.H. Kerns Profiling drug-like properties in discovery research Curr. Opin. Chem. Biol. 7 2003 402 408
-
(2003)
Curr. Opin. Chem. Biol.
, vol.7
, pp. 402-408
-
-
Di, L.1
Kerns, E.H.2
-
7
-
-
2142722247
-
Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates
-
L. Di, E.H. Kerns, H. Yan, T.A. Kleintop, O.J. McConnell, and D.M. Huryn Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates J. Biomol. Screen. 8 2003 453 462
-
(2003)
J. Biomol. Screen.
, vol.8
, pp. 453-462
-
-
Di, L.1
Kerns, E.H.2
Yan, H.3
Kleintop, T.A.4
McConnell, O.J.5
Huryn, D.M.6
-
8
-
-
2642513322
-
Experimental design on single time point high-throughput microsomal stability assay
-
L. Di, E.H. Kerns, N. Gao, S. Li, Y. Huang, J.L. Bourassa, and D.M. Huryn Experimental design on single time point high-throughput microsomal stability assay J. Pharm. Sci. 93 2004 1537 1544
-
(2004)
J. Pharm. Sci.
, vol.93
, pp. 1537-1544
-
-
Di, L.1
Kerns, E.H.2
Gao, N.3
Li, S.4
Huang, Y.5
Bourassa, J.L.6
Huryn, D.M.7
-
9
-
-
85081433871
-
-
Di, L., Kerns, E.H., Chen, H., Petusky, S.L., 2005. Development and application of an automated solution stability method, in review.
-
(2005)
Development and Application of An Automated Solution Stability Method, in Review
-
-
Di, L.1
Kerns, E.H.2
Chen, H.3
Petusky, S.L.4
-
10
-
-
2342481809
-
Lessons learned from marketed and investigational prodrugs
-
P. Ettmayer, G.L. Amidon, B. Clement, and B. Testa Lessons learned from marketed and investigational prodrugs J. Med. Chem. 47 2004 2393 2404
-
(2004)
J. Med. Chem.
, vol.47
, pp. 2393-2404
-
-
Ettmayer, P.1
Amidon, G.L.2
Clement, B.3
Testa, B.4
-
11
-
-
1642581054
-
A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives
-
R.B. Greenwald, H. Zhao, K. Yang, P. Reddy, and A. Martinez A new aliphatic amino prodrug system for the delivery of small molecules and proteins utilizing novel PEG derivatives J. Med. Chem. 47 2004 726 734
-
(2004)
J. Med. Chem.
, vol.47
, pp. 726-734
-
-
Greenwald, R.B.1
Zhao, H.2
Yang, K.3
Reddy, P.4
Martinez, A.5
-
12
-
-
15144359972
-
How an increase in the carbon chain length of the ester moiety affects the stability of a homologous series of oxprenolol esters in the presence of biological enzymes
-
C. Geraldine, and M. Jordan How an increase in the carbon chain length of the ester moiety affects the stability of a homologous series of oxprenolol esters in the presence of biological enzymes J. Pharm. Sci. 87 1998 880 885
-
(1998)
J. Pharm. Sci.
, vol.87
, pp. 880-885
-
-
Geraldine, C.1
Jordan, M.2
-
14
-
-
0037376928
-
Pharmaceutical profiling in drug discovery
-
E.H. Kerns, and L. Di Pharmaceutical profiling in drug discovery Drug Discov. Today 8 2003 316 323
-
(2003)
Drug Discov. Today
, vol.8
, pp. 316-323
-
-
Kerns, E.H.1
Di, L.2
-
15
-
-
0035150465
-
High throughput physicochemical profiling for drug discovery
-
E.H. Kerns High throughput physicochemical profiling for drug discovery J. Pharm. Sci. 90 2001 1838 1858
-
(2001)
J. Pharm. Sci.
, vol.90
, pp. 1838-1858
-
-
Kerns, E.H.1
-
16
-
-
0035837063
-
Synthesis and biological evaluation of novel a-ring modified hexacyclic camptothecin analogues
-
D.K. Kim, D.H. Ryu, J.Y. Lee, N. Lee, Y.W. Kim, J.S. Kim, K. Chang, G.J. Im, T.K. Kim, and W.S. Choi Synthesis and biological evaluation of novel a-ring modified hexacyclic camptothecin analogues J. Med. Chem. 44 2001 1594 1602
-
(2001)
J. Med. Chem.
, vol.44
, pp. 1594-1602
-
-
Kim, D.K.1
Ryu, D.H.2
Lee, J.Y.3
Lee, N.4
Kim, Y.W.5
Kim, J.S.6
Chang, K.7
Im, G.J.8
Kim, T.K.9
Choi, W.S.10
-
17
-
-
0033049029
-
Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 gilson liquid handler
-
J.M. Linget, and P. du Vignaud Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 gilson liquid handler J. Pharm. Biomed. Anal. 19 1999 893 901
-
(1999)
J. Pharm. Biomed. Anal.
, vol.19
, pp. 893-901
-
-
Linget, J.M.1
Du Vignaud, P.2
-
18
-
-
0032080488
-
Liquid chromatographic analysis in mouse, dog and human plasma; Stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1, 4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84)
-
A.A. Nomeir, M.F. McComish, N.F. Ferrala, D. Silveira, J.M. Covey, and M. Chadwick Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1, 4-oxathiin-3-yl carboxamido) isopropylbenzoate (NSC 615985, UC84) Pharm. Biomed. Anal. 17 1998 27 38
-
(1998)
Pharm. Biomed. Anal.
, vol.17
, pp. 27-38
-
-
Nomeir, A.A.1
McComish, M.F.2
Ferrala, N.F.3
Silveira, D.4
Covey, J.M.5
Chadwick, M.6
-
19
-
-
0032968630
-
Direct determination of stability of protease inhibitors in plasma by HPLC with automated column-switching
-
S.X. Peng, M.J. Strojnowski, and D.M. Bornes Direct determination of stability of protease inhibitors in plasma by HPLC with automated column-switching J. Pharm. Biomed. Anal. 25 1999 343 349
-
(1999)
J. Pharm. Biomed. Anal.
, vol.25
, pp. 343-349
-
-
Peng, S.X.1
Strojnowski, M.J.2
Bornes, D.M.3
-
20
-
-
0032721494
-
In vito and in vivo study of water-soluble prodrugs of dexanabinol
-
M. Pop, S. Rachwal, J. Vlasak, A. Biegon, A. Zharikova, and L. Prokai In vito and in vivo study of water-soluble prodrugs of dexanabinol J. Pharm. Sci. 88 1999 1156 1160
-
(1999)
J. Pharm. Sci.
, vol.88
, pp. 1156-1160
-
-
Pop, M.1
Rachwal, S.2
Vlasak, J.3
Biegon, A.4
Zharikova, A.5
Prokai, L.6
-
21
-
-
0031743198
-
In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen
-
J. Rautio, H. Taipale, J. Gynther, J. Vepsalainen, T. Nevalainen, and T. Jarvinen In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen J. Pharm. Sci. 87 1998 1622 1628
-
(1998)
J. Pharm. Sci.
, vol.87
, pp. 1622-1628
-
-
Rautio, J.1
Taipale, H.2
Gynther, J.3
Vepsalainen, J.4
Nevalainen, T.5
Jarvinen, T.6
-
22
-
-
0037075119
-
New strategy for antedrug application: Development of metalloproteinase inhibitor as antipsoriatic drugs
-
M. Sawa, T. Tsukamoto, T. Kiyoi, K. Kurokawa, F. Nakajima, Y. Nakada, K. Yokota, Y. Inoue, H. Kondo, and K. Yoshino New strategy for antedrug application: development of metalloproteinase inhibitor as antipsoriatic drugs J. Med. Chem. 45 2002 930 936
-
(2002)
J. Med. Chem.
, vol.45
, pp. 930-936
-
-
Sawa, M.1
Tsukamoto, T.2
Kiyoi, T.3
Kurokawa, K.4
Nakajima, F.5
Nakada, Y.6
Yokota, K.7
Inoue, Y.8
Kondo, H.9
Yoshino, K.10
-
23
-
-
85081435474
-
-
Personal communication.
-
Stella, V., 2005. Personal communication.
-
(2005)
-
-
Stella, V.1
-
24
-
-
0032920847
-
Synthesis stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs
-
C. Udata, G. Tirucherai, and A.K. Mitra Synthesis stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs J. Pharm. Sci. 1999 544 550
-
(1999)
J. Pharm. Sci.
, pp. 544-550
-
-
Udata, C.1
Tirucherai, G.2
Mitra, A.K.3
-
25
-
-
0037175444
-
Semi-automated determination of plasma stability of drug discovery compounds using liquid chromotography-tandem mass spectrometry
-
G. Wang, Y Hsieh, YY. Lau, K.C. Cheng, K. Ng, W.A. Korfmacher, and R.E. White Semi-automated determination of plasma stability of drug discovery compounds using liquid chromotography-tandem mass spectrometry J. Chromatogr. B 780 2002 451 457
-
(2002)
J. Chromatogr. B
, vol.780
, pp. 451-457
-
-
Wang, G.1
Hsieh, Y.2
Lau, Y.Y.3
Cheng, K.C.4
Ng, K.5
Korfmacher, W.A.6
White, R.E.7
|